Anti-B cell strategy for complicated steroid-dependent nephrotic syndrome in children with antirituximab antibodies

Pediatr Nephrol. 2022 Oct;37(10):2521-2522. doi: 10.1007/s00467-022-05612-3. Epub 2022 May 18.

Authors

Shuichiro Fujinaga¹, Shota Endo²

Affiliations

¹ Division of Nephrology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-ku, Saitama City, Saitama, 330-8777, Japan. f_shuich@d2.dion.ne.jp.
² Division of Nephrology, Saitama Children's Medical Center, 1-2 Shintoshin, Chuo-ku, Saitama City, Saitama, 330-8777, Japan.

PMID: 35585367
DOI: 10.1007/s00467-022-05612-3

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Antibodies
Child
Humans
Nephrotic Syndrome* / complications
Nephrotic Syndrome* / drug therapy
Recurrence
Rituximab / adverse effects
Steroids / therapeutic use

Substances

Antibodies
Steroids
Rituximab